Literature DB >> 807596

Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.

L G Krugman, J M Hershman, I J Chopra, G A Levine, E Pekary, D L Geffner, G N Chua Teco.   

Abstract

To determine the patterns of recovery of the hypothalamic-pituitary-thyroid axis following long-term thyroid hormone therapy, TRH tests were performed on 8 euthyroid nongoitrous patients, 5 euthyroid goitrous patients, and 5 hypothyroid patients while they were taking full doses of thyroid hormone and 3, 7, 10, 14, 17, 21, 28, 35, 42, 49, and 56 days after stopping it. Serum TSH, T3, and T4 were measured before and at multiple intervals over a 4-h period after giving 500 mug TRH iv. In euthyroid non-goitrous patients, the mean duration of suppressed TSH response to TRH (maximum deltaTSH less than 8 muU/ml) was 12 +/- 4 (SE) days after stopping thyroid hormone and the mean time to recovery of normal TSH response to TRH (maximum deltaTSH greater than 8 muU/ml) was 16 +/- 5 days. None of the euthyroid nongoitrous patients ever hyperresponded to TRH; their average maximal deltaTSH was 24.5 +/- 2.2 muU/ml. Serum T4 fell below normal in 4 euthyroid non-goitrous patients, reaching lowest values at 4 to 28 days. While serum T4 was low, deltaTSH was subnormal. Normal increments of T4 and T3 after TRH occurred at 19 +/- 5 and 22 +/- 6 days, respectively. In the 5 goitrous patients, patterns of recovery of pituitary and thyroid function assessed by the same parameters were much less consistent. In the 5 hypothyroid patients, the mean duration of suppressed basal TSH and suppressed deltaTSH was 13 +/- 3 days; mean time to attain a supranormal basal TSH (greater than 8 muU/ml) was 16 +/- 4 days and to reach a supranormal deltaTSH (greater than 38 muU/ml) after TRH was 29 +/- 8 days. Following prolonged thyroid therapy in euthyroid patients, recovery of normal TSH responsiveness to TRH preceded recovery of the normal T3 and T4 response to TRH by 3 to 6 days. Basal serum TSH may be used to differentiate euthyroid from hypothyroid patients 35 days after withdrawal of thyroid therapy; the response to TRH does not improve this differentiation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807596     DOI: 10.1210/jcem-41-1-70

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Unintentional thyrotoxicosis factitia due to a diet pill.

Authors:  G D Braunstein; R Koblin; M Sugawara; A E Pekary; J M Hershman
Journal:  West J Med       Date:  1986-09

3.  Thyroid hormone replacement.

Authors:  R Cygan; L Rucker
Journal:  West J Med       Date:  1983-08

4.  [Restitution of the thyrotropic function in goiter patients after discontinuing a long-term suppression therapy with thyroid hormones].

Authors:  M Hüfner; M Grussendorf; R Wahl; H D Röher
Journal:  Klin Wochenschr       Date:  1976-06-01

5.  Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.

Authors:  J L Vandalem; G Pirens; G Hennen
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

6.  Hypothalamic hypothyroidism due to isolated thyrotropin-releasing hormone (TRH) deficiency.

Authors:  H Katakami; Y Kato; M Inada; H Imura
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

7.  Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.

Authors:  S M Lum; J T Nicoloff; C A Spencer; E M Kaptein
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

8.  Isolated thyrotropin deficiency due to a pituitary tumour.

Authors:  H B Lee; C Faiman
Journal:  Can Med Assoc J       Date:  1977-03-05       Impact factor: 8.262

9.  Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis.

Authors:  E M Kaptein; W J Robinson; D A Grieb; J T Nicoloff
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

10.  Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis.

Authors:  Nydia Burgos; Freddy J K Toloza; Naykky M Singh Ospina; Juan P Brito; Ramzi G Salloum; Leslie C Hassett; Spyridoula Maraka
Journal:  Thyroid       Date:  2020-12-29       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.